{"id":"https://openalex.org/W2593045216","doi":"https://doi.org/10.1001/jamaoncol.2017.0041","title":"Clinical and Radiologic Responses to Cladribine for the Treatment of Erdheim-Chester Disease","display_name":"Clinical and Radiologic Responses to Cladribine for the Treatment of Erdheim-Chester Disease","publication_year":2017,"publication_date":"2017-03-02","ids":{"openalex":"https://openalex.org/W2593045216","doi":"https://doi.org/10.1001/jamaoncol.2017.0041","mag":"2593045216","pmid":"https://pubmed.ncbi.nlm.nih.gov/28253394","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5824289"},"language":"en","primary_location":{"id":"doi:10.1001/jamaoncol.2017.0041","doi":"https://doi.org/10.1001/jamaoncol.2017.0041","is_oa":true,"landing_page_url":"https://doi.org/10.1001/jamaoncol.2017.0041","pdf_url":"https://jamanetwork.com/journals/jamaoncology/articlepdf/2606436/jamaoncology_goyal_2017_br_170001.pdf","source":{"id":"https://openalex.org/S2756165422","display_name":"JAMA Oncology","issn_l":"2374-2437","issn":["2374-2437","2374-2445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://jamanetwork.com/journals/jamaoncology/articlepdf/2606436/jamaoncology_goyal_2017_br_170001.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056210769","display_name":"Gaurav Goyal","orcid":"https://orcid.org/0000-0001-6148-5177","observed_orcids":["https://orcid.org/0000-0001-6148-5177"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gaurav Goyal","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, Minnesota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, Minnesota","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020872528","display_name":"Mithun Vinod Shah","orcid":"https://orcid.org/0000-0002-5359-336X","observed_orcids":["https://orcid.org/0000-0002-5359-336X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mithun V. Shah","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, Minnesota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, Minnesota","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051752737","display_name":"Timothy G. Call","orcid":"https://orcid.org/0000-0002-8465-9587","observed_orcids":["https://orcid.org/0000-0002-8465-9587"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Timothy G. Call","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, Minnesota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, Minnesota","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085360755","display_name":"Mark Robert Litzow","orcid":"https://orcid.org/0000-0002-9816-6302","observed_orcids":["https://orcid.org/0000-0002-9816-6302"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark R. Litzow","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, Minnesota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, Minnesota","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084606047","display_name":"William J. Hogan","orcid":"https://orcid.org/0000-0002-5841-4105","observed_orcids":["https://orcid.org/0000-0002-5841-4105"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William J. Hogan","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, Minnesota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, Minnesota","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029802364","display_name":"Ronald S. Go","orcid":"https://orcid.org/0000-0002-8284-3495","observed_orcids":["https://orcid.org/0000-0002-8284-3495"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ronald S. Go","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, Minnesota"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, Minnesota","institution_ids":["https://openalex.org/I1330342723"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5029802364"],"corresponding_institution_ids":["https://openalex.org/I1330342723"],"apc_list":null,"apc_paid":null,"fwci":5.6394,"has_fulltext":true,"cited_by_count":73,"citation_normalized_percentile":{"value":0.96635012,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":99},"biblio":{"volume":"3","issue":"9","first_page":"1253","last_page":"1253"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11909","display_name":"Histiocytic Disorders and Treatments","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11909","display_name":"Histiocytic Disorders and Treatments","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11571","display_name":"Sarcoidosis and Beryllium Toxicity Research","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12600","display_name":"Eosinophilic Disorders and Syndromes","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/erdheim-chester-disease","display_name":"Erdheim-Chester disease","score":0.9919999837875366},{"id":"https://openalex.org/keywords/cladribine","display_name":"cladribine","score":0.9940000176429749},{"id":"https://openalex.org/keywords/myeloid-neoplasms","display_name":"myeloid neoplasms","score":0.9470000267028809},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.6930000185966492},{"id":"https://openalex.org/keywords/radiological-response","display_name":"radiological response","score":0.703000009059906},{"id":"https://openalex.org/keywords/clinical-response","display_name":"clinical response","score":0.6140000224113464},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.6690000295639038},{"id":"https://openalex.org/keywords/second-line-treatment","display_name":"second-line therapy","score":0.6169999837875366},{"id":"https://openalex.org/keywords/disease-progression","display_name":"disease progression","score":0.39399999380111694},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.34200000762939453},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.32499998807907104},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.3109999895095825},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.6880000233650208},{"id":"https://openalex.org/keywords/prognostic-score","display_name":"prognostic score","score":0.43799999356269836}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.950372576713562},{"id":"https://openalex.org/C2779200787","wikidata":"https://www.wikidata.org/wiki/Q414030","display_name":"Cladribine","level":2,"score":0.9411596059799194},{"id":"https://openalex.org/C2779945361","wikidata":"https://www.wikidata.org/wiki/Q1349259","display_name":"Erdheim\u2013Chester disease","level":4,"score":0.5093430280685425},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.5064932107925415},{"id":"https://openalex.org/C2781156865","wikidata":"https://www.wikidata.org/wiki/Q827023","display_name":"Lesion","level":2,"score":0.4747101366519928},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.44445785880088806},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.425260454416275},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.39594271779060364},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.32851722836494446},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3021712601184845},{"id":"https://openalex.org/C2780174970","wikidata":"https://www.wikidata.org/wiki/Q1411740","display_name":"Histiocytosis","level":3,"score":0.10363972187042236}],"mesh":[{"descriptor_ui":"D000072078","descriptor_name":"Positron Emission Tomography Computed Tomography","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008279","descriptor_name":"Magnetic Resonance Imaging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017338","descriptor_name":"Cladribine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017338","descriptor_name":"Cladribine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D031249","descriptor_name":"Erdheim-Chester Disease","qualifier_ui":"Q000000981","qualifier_name":"diagnostic imaging","is_major_topic":false},{"descriptor_ui":"D031249","descriptor_name":"Erdheim-Chester Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1001/jamaoncol.2017.0041","doi":"https://doi.org/10.1001/jamaoncol.2017.0041","is_oa":true,"landing_page_url":"https://doi.org/10.1001/jamaoncol.2017.0041","pdf_url":"https://jamanetwork.com/journals/jamaoncology/articlepdf/2606436/jamaoncology_goyal_2017_br_170001.pdf","source":{"id":"https://openalex.org/S2756165422","display_name":"JAMA Oncology","issn_l":"2374-2437","issn":["2374-2437","2374-2445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5824289","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5824289","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Oncol","raw_type":"Text"},{"id":"pmid:28253394","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28253394","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA oncology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1001/jamaoncol.2017.0041","doi":"https://doi.org/10.1001/jamaoncol.2017.0041","is_oa":true,"landing_page_url":"https://doi.org/10.1001/jamaoncol.2017.0041","pdf_url":"https://jamanetwork.com/journals/jamaoncology/articlepdf/2606436/jamaoncology_goyal_2017_br_170001.pdf","source":{"id":"https://openalex.org/S2756165422","display_name":"JAMA Oncology","issn_l":"2374-2437","issn":["2374-2437","2374-2445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320259","host_organization_name":"American Medical Association","host_organization_lineage":["https://openalex.org/P4310320259"],"host_organization_lineage_names":["American Medical Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAMA Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2593045216.pdf","grobid_xml":"https://content.openalex.org/works/W2593045216.grobid-xml"},"referenced_works_count":15,"referenced_works":["https://openalex.org/W1846586690","https://openalex.org/W1984562089","https://openalex.org/W2006268804","https://openalex.org/W2009978995","https://openalex.org/W2022095137","https://openalex.org/W2027620575","https://openalex.org/W2027757979","https://openalex.org/W2033757717","https://openalex.org/W2126417952","https://openalex.org/W2231656760","https://openalex.org/W2255194647","https://openalex.org/W2287006626","https://openalex.org/W2310716991","https://openalex.org/W2321482121","https://openalex.org/W2413475182"],"related_works":["https://openalex.org/W2412735193","https://openalex.org/W3164813164","https://openalex.org/W2585691811","https://openalex.org/W2411847809","https://openalex.org/W2321482121","https://openalex.org/W7214009534","https://openalex.org/W2009978995","https://openalex.org/W7160193770","https://openalex.org/W2287006626","https://openalex.org/W4289457315"],"abstract_inverted_index":{"IMPORTANCE:":[0],"While":[1],"cladribine":[2,35,270,304,352],"is":[3,460],"best":[4],"known":[5],"for":[6,196],"the":[7,32,38,73,110,154,248,267,283,294,354,441,455],"treatment":[8,39,92,285,292,442,450],"of":[9,34,40,75,119,128,146,163,175,205,216,230,242,259,269,301,303,318,322,329,336,343,357,380,388,395,443],"hairy":[10],"cell":[11],"leukemia":[12],"and":[13,105,142,199,239,254,289,326,340,392,407,414,422,424,445,464],"other":[14],"lymphoid":[15],"cancers,":[16],"it":[17],"also":[18],"has":[19,436],"activity":[20],"against":[21],"myeloid":[22],"neoplasms,":[23],"such":[24],"as":[25,282,290],"Erdheim-Chester":[26],"disease":[27,134,144,184,201,339,391],"(ECD).":[28],"OBJECTIVE:":[29],"To":[30],"assess":[31],"efficacy":[33,439],"(2-chloro-2'-deoxyadenosine)":[36],"in":[37,82,90,137,188,257,286,293,369,440,452,467],"ECD.":[41],"DESIGN,":[42],"SETTING,":[43],"AND":[44,97,433],"PARTICIPANTS:":[45],"This":[46],"study":[47],"was":[48,77,232,247,255,272,280,306,315,360,377],"a":[49,64,449,468],"single-institution":[50],"retrospective":[51],"medical":[52,67],"record":[53],"review":[54],"from":[55],"January":[56],"1,":[57],"1998,":[58],"to":[59,122,131,140,149,169,181,194,211,351],"April":[60],"6,":[61],"2016,":[62],"at":[63,228,266],"tertiary":[65],"academic":[66],"center.":[68],"In":[69],"all":[70],"eligible":[71],"cases,":[72],"diagnosis":[74,229],"ECD":[76,195,222,231,444],"made":[78],"using":[79],"clinical":[80,104,108,312,358,438],"criteria":[81,101,112],"conjunction":[83],"with":[84,220,333,366,385],"histopathologic":[85],"findings.":[86],"EXPOSURE:":[87],"Cladribine":[88,246,279,435],"therapy":[89,271,430],"first-line":[91,284],"or":[93,165,177,190,203,207],"later.":[94],"MAIN":[95],"OUTCOMES":[96],"MEASURES:":[98],"Two":[99],"response":[100,116,125,160,172,313,325,359,368,375],"were":[102,113,157,223,244],"used,":[103],"radiological.":[106],"For":[107,151],"response,":[109,153],"following":[111,155],"used:":[114,158],"complete":[115,159,324],"(complete":[117,161],"resolution":[118,127,162,174],"symptoms":[120,129,138,147],"attributed":[121,130,139,148],"ECD),":[123,132,141,170,182],"partial":[124,171,331,383],"(partial":[126,173],"stable":[133,183,338,390],"(no":[135,185],"change":[136,187],"progressive":[143,200,345,397],"(worsening":[145],"ECD).":[150,212],"radiological":[152,374],"categories":[156],"proven":[164,176,189,206],"suspected":[166,178,191,208],"lesion":[167,179,192,209],"due":[168,180,193,210],"significant":[186],"\u22653":[197],"months),":[198,365],"(progression":[202],"worsening":[204],"RESULTS:":[213],"A":[214],"total":[215],"63":[217,260],"adult":[218],"patients":[219,261,288,348],"confirmed":[221],"identified.":[224],"Their":[225,263],"median":[226,264,299,355],"age":[227,265],"54":[233],"years":[234,274],"(age":[235,275],"range,":[236,276],"18-80":[237],"years),":[238],"67%":[240],"(42":[241],"63)":[243],"male.":[245],"most":[249],"commonly":[250],"used":[251,281],"chemotherapeutic":[252],"agent":[253],"administered":[256,305],"21":[258],"(33%).":[262],"time":[268],"62":[273],"40-78":[277],"years).":[278],"9":[287,361],"later-line":[291],"remaining":[295],"12":[296],"patients.":[297,371],"The":[298,310,372],"number":[300],"cycles":[302],"2.5":[307],"(range,":[308,363],"1-6).":[309],"overall":[311,373],"rate":[314,376],"52%":[316],"(9":[317],"17)":[319,337,344],"(6%":[320],"[1":[321],"17]":[323,330],"46%":[327],"[8":[328],"response),":[332,384],"18%":[334],"(3":[335],"30%":[341],"(5":[342],"disease.":[346,398],"Among":[347],"who":[349],"responded":[350],"therapy,":[353],"duration":[356],"months":[362],"6-129":[364],"ongoing":[367],"2":[370,403,415],"54%":[378],"(8":[379],"15)":[381,389,396],"(all":[382],"26%":[386],"(4":[387],"20%":[393],"(2":[394],"Treatment-related":[399],"adverse":[400,417],"effects":[401,418],"included":[402],"infectious":[404],"complications":[405],"(pneumonia":[406],"central":[408],"line":[409],"infection,":[410],"both":[411,428],"requiring":[412,429],"hospitalization)":[413],"hematologic":[416],"(grade":[419],"4":[420],"neutropenia":[421],"thrombocytopenia,":[423],"grade":[425],"3":[426],"neutropenia,":[427],"discontinuation).":[431],"CONCLUSIONS":[432],"RELEVANCE:":[434],"moderate":[437],"can":[446],"be":[447],"considered":[448],"option":[451],"cases":[453],"without":[454],"BRAF":[456],"V600E":[457],"mutation.":[458],"It":[459],"generally":[461],"well":[462],"tolerated":[463],"may":[465],"result":[466],"durable":[469],"response.":[470]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":11},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":12},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-03-16T00:00:00"}